Skip to content
BIO urges Senate to confirm agricultural trade officials
It is time for the Senate to confirm two officials tasked with protecting ...
Read More
Data shows persistent inequities in U.S. COVID treatment trials, rare disease R&D
The lack of gender and racial diversity in medical R&D in the United ...
Read More
WHO report warns of the rise in antibiotic resistance, seeks better data
Common bacterial infections are becoming increasingly resistant to antibiotics, “causing life-threatening bloodstream infections,” ...
Read More
Mexico’s treatment of biotech corn needs urgent action, U.S. lawmakers say
Ahead of a key meeting between the U.S. and Mexico later this week, ...
Read More
Takeda’s dengue vaccine approved for use in the EU
Takeda announced the European Commission (EC) authorized the company’s new dengue vaccine for ...
Read More
U.S. punts decision on COVID IP waiver to 2023
Could the Office of the U.S. Trade Representative’s (USTR) position on the COVID ...
Read More
EDITORS' CHOICE
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More
LATEST NEWS
BIO's View
Putting Americans First: International prices in context
It is often taken as a given that drug prices in the U.S. are higher than those in other nations. And while there is a ...
Health
BIO’s Texas visit will highlight a growing biotech ecosystem
Already providing employment for 129,245 people and $95 billion in annual economic output, Texas’s biotech sector is growing rapidly. That sector will be highlighted Sept. ...
BIO's View
Putting Americans First: No medicine is more expensive than the one patients can’t access
The most notable differences between the pharmaceutical market in the U.S. and those in other countries are not in the prices. They’re in the ability ...
Federal Policy
BIO Coffee Chat looks at patient access after three years of the IRA
It has been three years since the Inflation Reduction Act (IRA) was signed into law. “We have definitively seen negative impacts on patient access, and ...
BIO Events
Riboway Therapeutics: Resilience, RNA, and redefining the undruggable
At this year’s BIO International Convention in Boston, Riboway Therapeutics emerged as the winner of the 2025 BIO Start-Up Stadium seed-stage category. For founder and CEO ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
BIO’s Texas visit will highlight a growing biotech ecosystem
Already providing employment for 129,245 people and $95 billion in annual economic output, Texas’s biotech sector is growing rapidly. That ...
Read More
International
Bio's View
Putting Americans First: International prices in context
It is often taken as a given that drug prices in the U.S. are higher than those in other nations. ...
Read More
